ALZHEIMER'S DISEASE: MECHANISMS OF TAU AND AMYLOID BETA-INDUCED EXCITOTOXICITY

被引：0
|
作者：
Lin, Xiaotong [1 ]
Yan, Tingting [1 ]
机构：
[1] Harbin Inst Technol, Dept Bioengn, Weihai 264209, Shandong, Peoples R China
来源：
PROCEEDINGS OF THE 2016 INTERNATIONAL CONFERENCE ON BIOTECHNOLOGY & MEDICAL SCIENCE | 2017年
基金：
中国国家自然科学基金;
关键词：
NEURODEGENERATIVE DISEASES; GLUTAMATE; RECEPTORS; PROTEINS;
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Excitotoxicity is associated with various neurodegenerative diseases, among which Alzheimer's disease (AD) and Parkinson disease (PD) are the typical diseases. AD is a representative degenerative disease with clinical characteristics of senile plaques (SPs), neurofibrillary tangles (NFTs) and neuronal loss. Excitotoxicity has been considered as a mechanism of AD pathogenesis, which may induced by excessive accumulation of glutamate.
引用
收藏
页码：386 / 391
页数：6
相关论文
共 50 条
  • [41] Amyloid-β and Tau at the Crossroads of Alzheimer's Disease
    Gallardo, Gilbert
    Holtzman, David M.
    [J]. TAU BIOLOGY, 2019, 1184 : 187 - 203
  • [42] LIPID RAFTS IN AMYLOID BETA ENDOCYTOSIS AND AMYLOID BETA-INDUCED APOPTOSIS
    de Chaves, Posse E., I
    Mohamed, A.
    Saavedra, L.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 146 - 146
  • [43] Amyloid β, Glutamate, Excitotoxicity in Alzheimer's Disease: Are We on the Right Track?
    Esposito, Zaira
    Belli, Lorena
    Toniolo, Sofia
    Sancesario, Giuseppe
    Bianconi, Claudio
    Martorana, Alessandro
    [J]. CNS NEUROSCIENCE & THERAPEUTICS, 2013, 19 (08) : 549 - 555
  • [44] Protective Effects of BACE1 Inhibitory Ligand Against Amyloid Beta-Induced Synaptic and Mitochondrial Toxicities in Alzheimer's Disease
    Pradeepkiran, J. A.
    Yin, Xiangling
    Reddy, Arubala P.
    Manczak, Maria
    Reddy, P. Hemachandra
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2019, 72 : S22 - S23
  • [45] Osmotin attenuates amyloid beta-induced memory impairment, tau phosphorylation and neurodegeneration in the mouse hippocampus
    Tahir Ali
    Gwang Ho Yoon
    Shahid Ali Shah
    Hae Young Lee
    Myeong Ok Kim
    [J]. Scientific Reports, 5
  • [46] Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease
    Mullins, Roger J.
    Diehl, Thomas C.
    Chia, Chee W.
    Kapogiannis, Dimitrios
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2017, 9
  • [47] Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies
    Lue L.-F.
    Guerra A.
    Walker D.G.
    [J]. Neurology and Therapy, 2017, 6 (Suppl 1) : 25 - 36
  • [48] THE SYNERGISTIC INTERPLAY OF AMYLOID BETA AND TAU PROTEINS IN ALZHEIMER'S DISEASE: A COMPARTMENTAL MATHEMATICAL MODEL
    Tesi, Maria Carla
    [J]. BRUNO PINI MATHEMATICAL ANALYSIS SEMINAR, 2021, 12 (01) : 15 - 30
  • [49] Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas
    Jurre den Haan
    Tjado H. J. Morrema
    Frank D. Verbraak
    Johannes F. de Boer
    Philip Scheltens
    Annemieke J. Rozemuller
    Arthur A. B. Bergen
    Femke H. Bouwman
    Jeroen J. Hoozemans
    [J]. Acta Neuropathologica Communications, 6
  • [50] Amyloid-beta and phosphorylated tau in post-mortem Alzheimer's disease retinas
    den Haan, Jurre
    Morrema, Tjado H. J.
    Verbraak, Frank D.
    de Boer, Johannes F.
    Scheltens, Philip
    Rozemuller, Annemieke J.
    Bergen, Arthur A. B.
    Bouwman, Femke H.
    Hoozemans, Jeroen J.
    [J]. ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2018, 6 : 147
12345